This section is not available in the published analysis.
BridgeBio: Business overview
BridgeBio is a biotechnology company dedicated to designing transformative medicines specifically for patients suffering from genetic diseases and cancers with clear genetic drivers. The company focuses on the development and commercialization of precision medicines to address unmet medical needs.